Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of tumoral calcinosis with phosphorus deprivation.

× No keyword cloud information.

16 in total

Review 1. Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho).

Authors: Emily G Farrow; Erik A Imel; Kenneth E White
Journal: Best Pract Res Clin Rheumatol Date: 2011-10 Impact factor: 4.098

2. Tumoral calcinosis revisited--common and uncommon features. Report of ten cases and review.

Authors: A Metzker; B Eisenstein; J Oren; R Samuel
Journal: Eur J Pediatr Date: 1988-02 Impact factor: 3.183

3. Effects of the acute subcutaneous administration of synthetic salmon calcitonin in tumoral calcinosis.

Authors: R Candrina; B Cerudelli; V Braga; A Salvi
Journal: J Endocrinol Invest Date: 1989-01 Impact factor: 4.256

4. Tumorous calcinosis: a disease of its own?

Authors: W Braun; E Mayr; K Kundel; A Rüter
Journal: Arch Orthop Trauma Surg Date: 1996 Impact factor: 3.067

5. Case report 500: Tumoral calcinosis in area of left hip.

Authors: M Zawin; L D Katz; J P Lawson
Journal: Skeletal Radiol Date: 1988 Impact factor: 2.199

6. Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia?

Authors: Debora Claramunt-Taberner; Aurélia Bertholet-Thomas; Marie-Christine Carlier; Frédérique Dijoud; Franck Chotel; Caroline Silve; Justine Bacchetta
Journal: Pediatr Nephrol Date: 2018-03-28 Impact factor: 3.714

Treatment of tumoral calcinosis with phosphorus deprivation.

Review 1. Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho).

2. Tumoral calcinosis revisited--common and uncommon features. Report of ten cases and review.

3. Effects of the acute subcutaneous administration of synthetic salmon calcitonin in tumoral calcinosis.

4. Tumorous calcinosis: a disease of its own?

5. Case report 500: Tumoral calcinosis in area of left hip.

6. Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia?

Review 7. Review of tumoral calcinosis: A rare clinico-pathological entity.

8. A rare case report of tumoral calcinosis syndrome in an adult with rheumatoid arthritis.

9. Tumoral calcinosis revisited: pathophysiology and treatment.

10. Tumoral calcinosis: serial images to monitor successful dietary therapy.